Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Nuclear Medicine Communications|October 19, 2001
Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseasesC Prunier, F Tranquart, J P Cottier, et al.
Journal of Clinical Pharmacology|March 24, 2006
Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjectsS S Jhee, A S Chappell, V Zarotsky, et al.
Dementia and Geriatric Cognitive Disorders|October 11, 2013
Neuroinflammation and β amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imagingC Hommet, K Mondon, V Camus, et al.
Life Sciences|January 6, 2000
A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experimentsJ Helfenbein, C Loc'h, M Bottlaender, et al.
Experimental Neurology|January 15, 2005
Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamusI J Bohr, M A Ray, J M McIntosh, et al.
Nuclear Medicine and Biology|September 3, 1999
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporterJ Helfenbein, J Sandell, C Halldin, et al.
European Journal of Nuclear Medicine|June 18, 1998
Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imagingJ T Kuikka, J L Baulieu, J Hiltunen, et al.
Pageof 9